Actively Recruiting
An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2024-12-06
65
Participants Needed
12
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a pilot, observational, retrospective, and (italian) multicenter study. The study will involve the collection of patient data from medical records for patients with Multicentric Castelman Disease Relapsed/Refractory who received treatment with at least one dose of siltuximab, as part of standard of care in a real-life context, from July 2016 till April 2022 in 31selected italian centres.
CONDITIONS
Official Title
An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed diagnosis of relapsed or refractory Multicentric Castleman Disease (MCD) in HIV and HHV-8 negative patients treated with siltuximab from July 2016 to April 2022
- Age 18 years or older at enrollment
- Signed written informed consent (where applicable)
You will not qualify if you...
- Patients with relapsed or refractory MCD who received siltuximab as part of a clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
2
Azienda Ospedaliera Sant'Anna e San Sebastiano
Caserta, Caserta, Italy, 81100
Actively Recruiting
3
Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico
Bari, Italy, 70124
Actively Recruiting
4
Azienda Ospedaliera Universitaria Arcispedale Sant'Anna
Ferrara, Italy, 44124
Actively Recruiting
5
Azienda Ospedaliero Universitaria Careggi
Florence, Italy, 50134
Actively Recruiting
6
Irccs Ospedale San Raffaele
Milan, Italy, 20100
Actively Recruiting
7
Azienda Ospedaliero-Universitaria "Maggiore della Carità"
Novara, Italy, 28100
Actively Recruiting
8
Azienda Ospedaliera Di Padova
Padova, Italy, 35128
Actively Recruiting
9
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy, 27100
Actively Recruiting
10
Azienda Ospedaliera Universitaria Senese
Siena, Italy, 53100
Actively Recruiting
11
Azienda ULSS 2 Marca Trevigiana - UOC Medicina Interna 1 Centro di Riferimento per le Malattie Rare del Sistema Immunitario e dell'Apparato Respiratorio
Treviso, Italy, 31100
Actively Recruiting
12
Azienda Ulss 2 Marca Trevigiana- Ospedale Di Treviso
Treviso, Italy, 31100
Actively Recruiting
Research Team
P
Pier Luigi Zinzani, MD
CONTACT
B
Beatrice Casadei, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here